• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Microbiol . Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs

tetano

Editor, Senior Moderator
Nat Microbiol


. 2020 Aug 24.
doi: 10.1038/s41564-020-0778-x. Online ahead of print.
Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs


Vy Tran[SUP] 1 [/SUP], Mitchell P Ledwith[SUP] 1 [/SUP], Thiprampai Thamamongood[SUP] 2 3 4 5 [/SUP], Christina A Higgins[SUP] 1 [/SUP], Shashank Tripathi[SUP] 6 7 [/SUP], Max W Chang[SUP] 8 [/SUP], Christopher Benner[SUP] 8 [/SUP], Adolfo Garc?a-Sastre[SUP] 6 7 9 [/SUP], Martin Schwemmle[SUP] 2 3 [/SUP], Adrianus C M Boon[SUP] 10 [/SUP], Michael S Diamond[SUP] 10 [/SUP], Andrew Mehle[SUP] 11 [/SUP]



Affiliations

Abstract

Cells infected by influenza virus mount a large-scale antiviral response and most cells ultimately initiate cell-death pathways in an attempt to suppress viral replication. We performed a CRISPR-Cas9-knockout selection designed to identify host factors required for replication after viral entry. We identified a large class of presumptive antiviral factors that unexpectedly act as important proviral enhancers during influenza virus infection. One of these, IFIT2, is an interferon-stimulated gene with well-established antiviral activity but limited mechanistic understanding. As opposed to suppressing infection, we show in the present study that IFIT2 is instead repurposed by influenza virus to promote viral gene expression. CLIP-seq demonstrated that IFIT2 binds directly to viral and cellular messenger RNAs in AU-rich regions, with bound cellular transcripts enriched in interferon-stimulated mRNAs. Polysome and ribosome profiling revealed that IFIT2 prevents ribosome pausing on bound mRNAs. Together, the data link IFIT2 binding to enhanced translational efficiency for viral and cellular mRNAs and ultimately viral replication. Our findings establish a model for the normal function of IFIT2 as a protein that increases translation of cellular mRNAs to support antiviral responses and explain how influenza virus uses this same activity to redirect a classically antiviral protein into a proviral effector.
 
Back
Top Bottom